{
    "case_number": "CAC-UDRP-106487",
    "time_of_filling": "2024-05-03 16:36:21",
    "domain_names": [
        "novartisteam.com"
    ],
    "case_administrator": "Olga Dvořáková (Case admin)",
    "complainant": [
        "Novartis AG"
    ],
    "complainant_representative": "BRANDIT GmbH",
    "respondent": [
        "Jennifer  Stoller (Novartis )"
    ],
    "respondent_representative": null,
    "factual_background": "<p>The Complainant is the holding company of the Novartis Group, which is one of the biggest global pharmaceutical and healthcare groups. &nbsp;The Complainant owns numerous trademark registrations for the mark NOVATIS, including in the US where the Respondent is located. These registrations predate the registration of the disputed domain name. The Complainant also owns numerous domain names incorporating its trademark NOVARTIS, including &lt;novartis.com&gt; created on 2 April 1996.&nbsp;<\/p>\n<p>The Respondent registered the disputed domain name on 22 February 2024 using a privacy service.<\/p>\n<p>On 15 March 2024, the Complainant sent a cease and desist letter to the registrant but received no reply.<\/p>",
    "other_legal_proceedings": "<p>The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>",
    "no_response_filed": "<p>The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it. <br \/>No administratively compliant Response has been filed.<\/p>",
    "rights": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
    "no_rights_or_legitimate_interests": "<p>The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
    "bad_faith": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
    "procedural_factors": "<p>The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
    "decision": "Accepted",
    "panelists": [
        "Veronica  Bailey"
    ],
    "date_of_panel_decision": "2024-06-12 00:00:00",
    "informal_english_translation": "<p>The Complainant owns numerous trademark registrations for NOVARTIS, including the following US trademark registrations:<\/p>\n<ul>\n<li>Registration number 4986124, registered 28 June 2016;<\/li>\n<li>Registration Number 2336960, registered 4 April 2000; and<\/li>\n<li>Registration Number 5420583 registered&nbsp; 13 March 2018.<\/li>\n<\/ul>",
    "decision_domains": {
        "novartisteam.com": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}